Metastatic Colorectal Cancers Terminated Phase 2 Trials for Erlotinib (DB00530)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00459901Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTreatment
NCT00642746Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)Treatment